Dow Up 0.07% Nasdaq Up 0.61%

Clovis Oncology, Inc. (CLVS)

-NasdaqGS
48.20 0.75(1.58%) Nov 26, 4:00PM EST
Prev Close:47.45
Open:47.31
Bid:47.01 x 200
Ask:50.43 x 1000
1y Target Est:84.89
Beta:2.52
Earnings Date:Feb 25 - Mar 2 (Est.)
Day's Range:47.07 - 48.67
52wk Range:35.33 - 93.33
Volume:631,824
Avg Vol (3m):865,315
Market Cap:1.64B
P/E (ttm):N/A
EPS (ttm):-4.03
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CLVS

Comparison

Symbol% ChgMkt Cap
CLVSUp 1.58%1.64B
IMMU383.71M
LRUSFN/A
THLD184.49M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):118.28
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-4.41
Quarterly EPS Est (Dec-14) :-1.30
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback